311 related articles for article (PubMed ID: 21715020)
1. The role of BST2/tetherin in feline retrovirus infection.
Dietrich I; Hosie MJ; Willett BJ
Vet Immunol Immunopathol; 2011 Oct; 143(3-4):255-64. PubMed ID: 21715020
[TBL] [Abstract][Full Text] [Related]
2. Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.
Dietrich I; McMonagle EL; Petit SJ; Vijayakrishnan S; Logan N; Chan CN; Towers GJ; Hosie MJ; Willett BJ
J Virol; 2011 Jun; 85(12):5840-52. PubMed ID: 21490095
[TBL] [Abstract][Full Text] [Related]
3. Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein.
Celestino M; Calistri A; Del Vecchio C; Salata C; Chiuppesi F; Pistello M; Borsetti A; Palù G; Parolin C
J Virol; 2012 Jun; 86(12):6688-700. PubMed ID: 22514338
[TBL] [Abstract][Full Text] [Related]
4. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
[TBL] [Abstract][Full Text] [Related]
5. Expression of APOBEC3 Lentiviral Restriction Factors in Cats.
Troyer RM; Malmberg JL; Zheng X; Miller C; MacMillan M; Sprague WS; Wood BA; VandeWoude S
Viruses; 2019 Sep; 11(9):. PubMed ID: 31500260
[TBL] [Abstract][Full Text] [Related]
6. The Feline Immunodeficiency Virus Envelope Signal Peptide Is a Tetherin Antagonizing Protein.
Morrison JH; Poeschla EM
mBio; 2023 Apr; 14(2):e0016123. PubMed ID: 36927083
[TBL] [Abstract][Full Text] [Related]
7. Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV.
VandeWoude S; Troyer J; Poss M
Vet Immunol Immunopathol; 2010 Mar; 134(1-2):25-32. PubMed ID: 19896218
[TBL] [Abstract][Full Text] [Related]
8. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
[TBL] [Abstract][Full Text] [Related]
9. Cellular restriction factors of feline immunodeficiency virus.
Zielonka J; Münk C
Viruses; 2011 Oct; 3(10):1986-2005. PubMed ID: 22069525
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Investigation on the Interplay between Feline APOBEC3Z3 Proteins and Feline Immunodeficiency Virus Vif Proteins.
Kosugi Y; Uriu K; Suzuki N; Yamamoto K; Nagaoka S; Kimura I; Konno Y; Aso H; Willett BJ; Kobayashi T; Koyanagi Y; Ueda MT; Ito J; Sato K
J Virol; 2021 Jun; 95(13):e0017821. PubMed ID: 33762419
[TBL] [Abstract][Full Text] [Related]
11. Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?
Zhang Z; Gu Q; Marino D; Lee KL; Kong IK; Häussinger D; Münk C
Viruses; 2018 Apr; 10(4):. PubMed ID: 29642583
[TBL] [Abstract][Full Text] [Related]
12. Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.
Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Misawa N; Kimura Y; Ren F; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331087
[TBL] [Abstract][Full Text] [Related]
13. Differential type 1 interferon-regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence.
Polyak MJ; Vivithanaporn P; Maingat FG; Walsh JG; Branton W; Cohen EA; Meeker R; Power C
FASEB J; 2013 Jul; 27(7):2829-44. PubMed ID: 23608145
[TBL] [Abstract][Full Text] [Related]
14. Variation in Intra-individual Lentiviral Evolution Rates: a Systematic Review of Human, Nonhuman Primate, and Felid Species.
Krakoff E; Gagne RB; VandeWoude S; Carver S
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167917
[TBL] [Abstract][Full Text] [Related]
15. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids.
Zielonka J; Marino D; Hofmann H; Yuhki N; Löchelt M; Münk C
J Virol; 2010 Jul; 84(14):7312-24. PubMed ID: 20444897
[TBL] [Abstract][Full Text] [Related]
16. Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.
Troyer RM; Thompson J; Elder JH; VandeWoude S
J Virol; 2013 Jul; 87(14):7940-51. PubMed ID: 23658451
[TBL] [Abstract][Full Text] [Related]
17. Feline immunodeficiency virus dendritic cell infection and transfer.
Sprague WS; Robbiani M; Avery PR; O'Halloran KP; Hoover EA
J Gen Virol; 2008 Mar; 89(Pt 3):709-715. PubMed ID: 18272762
[TBL] [Abstract][Full Text] [Related]
18. Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.
Ledesma-Feliciano C; Hagen S; Troyer R; Zheng X; Musselman E; Slavkovic Lukic D; Franke AM; Maeda D; Zielonka J; Münk C; Wei G; VandeWoude S; Löchelt M
Retrovirology; 2018 May; 15(1):38. PubMed ID: 29769087
[TBL] [Abstract][Full Text] [Related]
19. The molecular biology of feline immunodeficiency virus (FIV).
Kenyon JC; Lever AM
Viruses; 2011 Nov; 3(11):2192-213. PubMed ID: 22163340
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
